1. Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (EDGE). Issue 10 (21st August 2013) Authors: Mathieu, C.; Barnett, A. H.; Brath, H.; Conget, I.; de, J. J.; Göke, R.; Márquez Rodriguez, E.; Nilsson, P. M.; Pagkalos, E.; Penfornis, A.; Schaper, N.C.; Wangnoo, S. K.; Kothny, W.; Bader, G. Journal: International journal of clinical practice Issue: Volume 67:Issue 10(2013) Page Start: 947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial. Issue 2 (15th January 2017) Authors: Schütz‐Fuhrmann, I.; Castañeda, J.; Reznik, Y.; Aronson, R.; Conget, I.; Liabat, S.; Runzis, S.; de Portu, S.; Cohen, O. Journal: Diabetic medicine Issue: Volume 34:Issue 2(2017) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial. Issue 2 (February 2017) Authors: Schütz‐Fuhrmann, I.; Castañeda, J.; Reznik, Y.; Aronson, R.; Conget, I.; Liabat, S.; Runzis, S.; de Portu, S.; Cohen, O. Journal: Diabetic medicine Issue: Volume 34:Issue 2(2017) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IDF2022-0312 Physical activity patterns in type 1 diabetes in Spain. The SED1 study. (March 2023) Authors: Gomez-Peralta, F.; Menéndez, E.; Conde, S.; Conget, I.; Novials, A. Journal: Diabetes research and clinical practice Issue: Volume 197(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Issue 10 (28th April 2016) Authors: Quirós, C.; Giménez, M.; Ríos, P.; Careaga, M.; Roca, D.; Vidal, M.; Conget, I. Journal: Diabetic medicine Issue: Volume 33:Issue 10(2016:Oct.) Page Start: 1422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Preeclampsia: A Risk Factor On Preclinical Carotid Atherosclerosis With Similar Impact To Type 1 Diabetes. (August 2019) Authors: Amor, A.J.; Vinagre, I.; Valverde, M.; Pané, A.; Urquizu, X.; Meler, E.; López, E.; Quirós, C.; Giménez, M.; Codina, L.; Alonso, N.; Conget, I.; Barahona, M.J.; Perea, V. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Steno type 1 risk engine and preclinical atherosclerosis in Mediterranean individuals with type 1 diabetes. Issue 7 (13th April 2020) Authors: Viñals, C.; Conget, I.; Pané, A.; Boswell, L.; Perea, V.; Blanco, A. J.; Ruiz, S.; Giménez, M.; Vinagre, I.; Esmatjes, E.; Ortega, E.; Amor, A. J. Journal: Diabetes/metabolism research and reviews Issue: Volume 36:Issue 7(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial. Issue 5 (22nd March 2016) Authors: Aronson, R.; Reznik, Y.; Conget, I.; Castañeda, J. A.; Runzis, S.; Lee, S. W.; Cohen, O. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 5(2016) Page Start: 500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗